Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

11.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
11.9K
Ligand Binding Sites02:40

Ligand Binding Sites

6.0K
6.0K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

10.6K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
10.6K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

4.4K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.4K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

3.0K
3.0K
Conserved Binding Sites01:49

Conserved Binding Sites

4.1K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling the Sensitivity of Large-Scale Virtual Screening to Scoring Function Accuracy, Artifacts, and Library Composition.

Journal of chemical information and modeling·2026
Same author

Library Docking for Cannabinoid-2 Receptor Ligands.

Journal of medicinal chemistry·2026
Same author

In-depth multimodal validation of <sup>18</sup>F-THK5351 for imaging monoamine oxidase-B-mediated reactive astrogliosis in Alzheimer's and related neurodegenerative diseases.

Experimental & molecular medicine·2026
Same author

Toward a Random Background for Ligand Optimization.

bioRxiv : the preprint server for biology·2026
Same author

The Selectivity Implications of Docking Libraries with Greater and Lesser Similarities to Bio-like Molecules.

Journal of medicinal chemistry·2026
Same author

Drug-Induced Phospholipidosis as an Artifact in Antiviral Drug Repurposing.

ACS omega·2026

Related Experiment Video

Updated: May 7, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

331

Ligand pose and orientational sampling in molecular docking.

Ryan G Coleman1, Michael Carchia, Teague Sterling

  • 1Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, United States of America.

Plos One
|October 8, 2013
PubMed
Summary
This summary is machine-generated.

Optimizing molecular docking software (DOCK3.6) with enhanced sampling and efficiency increased ligand enrichment over decoys. These improvements in computational methods are broadly applicable for drug discovery screening.

More Related Videos

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.6K
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

1.3K

Related Experiment Videos

Last Updated: May 7, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

331
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.6K
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

1.3K

Area of Science:

  • Computational chemistry and molecular modeling.
  • Structure-based drug design and virtual screening.

Background:

  • Molecular docking is crucial for identifying novel ligands and chemical probes.
  • Increasing complexity of targets and scoring functions necessitates improved reliability, scalability, and throughput in docking methods.

Purpose of the Study:

  • To explore sampling techniques for eliminating stochasticity in DOCK3.6.
  • To optimize DOCK3.6 for efficient and variable orientation sampling.
  • To enhance the enrichment of true ligands over decoys in virtual screening.

Main Methods:

  • Implemented deterministic sampling techniques in DOCK3.6 to ensure reproducible orientation sampling.
  • Optimized the DOCK3.6 code for computational efficiency, achieving a three-fold speed increase.
  • Conducted extensive benchmarking on the Directory of Useful Decoys-Enhanced (DUD-E) dataset, testing multiple sampling levels.

Main Results:

  • Increased molecular orientation sampling from 50 to 20,000 per binding site monotonically improved ligand enrichment over decoys across most DUD-E targets.
  • Inclusion of internal electrostatics for ligand conformational energies and restriction of aromatic hydroxyl rotamers further boosted enrichment values.
  • The optimized DOCK3.6 code demonstrated a significant increase in speed and efficiency.

Conclusions:

  • Deterministic and efficient sampling strategies in molecular docking enhance the reliability and performance of virtual screening.
  • Increased sampling density directly correlates with improved enrichment of true ligands, a key metric in docking performance.
  • The developed optimization strategies offer broad applicability for improving computational efficiency in molecular docking across the field.